2QNI
Crystal structure of uncharacterized protein Atu0299
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CHESS BEAMLINE A1 |
Synchrotron site | CHESS |
Beamline | A1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-05-05 |
Detector | ADSC QUANTUM 210 |
Wavelength(s) | 0.97600 |
Spacegroup name | H 3 2 |
Unit cell lengths | 111.347, 111.347, 136.020 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 50.000 - 1.800 |
R-factor | 0.19998 |
Rwork | 0.199 |
R-free | 0.22067 |
Structure solution method | SAD |
RMSD bond length | 0.009 |
RMSD bond angle | 1.138 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | SOLVE |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.860 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.061 | 0.749 |
Number of reflections | 88206 | |
<I/σ(I)> | 10.9 | 1.92 |
Completeness [%] | 99.9 | 99.3 |
Redundancy | 7.5 | 6.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4.6 | 297 | 0.1M Na(OAC) pH 4.6, 3.5M Sodium formate. THE CRYSTAL WAS OBTAINED BY IN SITU PROTEOLYSIS, PROTEIN SAMPLE WAS MIXED WITH 1:100 WEIGHT TO WEIGHT RATIO WITH CHYMOTRYPSIN IMMEDIATELY PRIOR TO SETTING UP CRYSTALLIZATION, VAPOR DIFFUSION, SITTING DROP, temperature 297K |